SAN FRANCISCO--(BUSINESS WIRE)--surgical.ai, a permanent capital vehicle focused on surgical automation, robotics and software, today announced its meaningful participation in a $180 million Series C round for Caresyntax. Caresyntax is a leader in the fast growing data-assisted surgery category. The investment will accelerate the adoption and development of Caresyntax's AI-enabled surgical software and fund strategic M&A activity.
Caresyntax's data-assisted surgery platform addresses critical data shortfalls and fragmentation challenges that have hindered the progress of precision surgery across the $3 trillion global surgical market. By collecting, integrating, and analyzing comprehensive data with AI, Caresyntax provides real-time and long-term clinical decision support to improve patient journeys, increase hospital operational efficiency, and achieve better outcomes.
Caresyntax's platform acts as a copilot for surgeons by collecting, integrating, and analyzing data before, during, and after surgical operations. By linking data from disparate sources on a unified vendor-neutral platform, Caresyntax supports surgeons in optimal preparation, helps patients understand and prepare for their procedures, and assists surgical teams in managing their workflows to minimize risk from procedural variance. The platform's comprehensive data collection and analysis capabilities also enables post-surgical risk assessment and tailored patient care, leading to faster recovery times, reduced costs, and improved overall healthcare delivery.
Currently, Caresyntax's software is used by over 30,000 surgical professionals across more than 3,500 operating rooms worldwide, making more than 3 million surgical procedures safer and smarter annually. The new funding will allow Caresyntax to accelerate commercial scaling and adoption of its precision surgery platform, enhance its AI and edge-to-cloud applications, and support strategic acquisitions that will expand its reach and technological offerings in the surgical automation space.
surgical.ai participated in the funding round with a combined eight figure investment alongside several leading strategic and financial investors including Symbiotic Capital, MTIP AG, Pictet Alternative Advisors, Aescuvest, PFM Health Sciences, BlackRock, Optum Ventures, Relyens, and others.
About surgical.ai
surgical.ai invests in and guides the most innovative companies in surgery. By supporting the creators of technology for the most complex, critical, and costly spaces in modern medicine, we are accelerating progress. We believe in a future where surgery is as safe as flying, insurance is functional, and doctors can focus on practicing medicine rather than processing paperwork. By weaving software and artificial intelligence throughout existing healthcare infrastructure, surgical.ai is not only reducing costs but ushering in an entirely new level of human healthcare. To learn more visit: www.surgical.ai
About Caresyntax
Caresyntax is on a mission to make surgery smarter and safer by converging AI-powered software, devices, and clinical services to improve patient outcomes. Our vendor-neutral, precision surgery platform delivers actionable insights to improve patient outcomes. Our proprietary software and AI platform is capturing and analyzing large volumes of video, audio, images, device data, clinical and operational data in and around the OR. The software and automation platform can be used by the care team live, during a procedure, and accessed by those outside the operating room via the platform’s secured dedicated cloud and telehealth links. The Caresyntax platform provides meta-data insights and real-world evidence (RWE) that help surgeons and teams to improve their care, hospital administrators to use resources more efficiently, and medical device companies to advance products. It also supports insurance companies to understand and control risks, as well as enable contracts on a value-based model. Headquartered in San Francisco and in Berlin, Caresyntax software is being used in more than 3,500 operating rooms worldwide and supports surgical teams in more than three million procedures per year. For more information, visit www.caresyntax.com
